 Premal Trivedi
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Portasystemic Shunt, Transjugular Intrahepatic | 5 | 2021 | 41 | 3.220 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 37 | 2.640 |
Why?
| | Radiology, Interventional | 4 | 2024 | 30 | 2.600 |
Why?
| | Vena Cava Filters | 7 | 2023 | 60 | 2.120 |
Why?
| | Ischemic Attack, Transient | 3 | 2022 | 60 | 2.080 |
Why?
| | Radiology | 3 | 2023 | 159 | 1.510 |
Why?
| | Medicare | 7 | 2022 | 716 | 1.350 |
Why?
| | Practice Patterns, Physicians' | 6 | 2021 | 1257 | 1.260 |
Why?
| | Cholestasis | 2 | 2023 | 231 | 1.240 |
Why?
| | Gastrointestinal Hemorrhage | 3 | 2021 | 123 | 1.010 |
Why?
| | Pulmonary Embolism | 4 | 2021 | 212 | 0.970 |
Why?
| | Renal Dialysis | 2 | 2020 | 423 | 0.950 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 458 | 0.900 |
Why?
| | United States | 22 | 2024 | 13865 | 0.860 |
Why?
| | Hyperaldosteronism | 1 | 2023 | 7 | 0.850 |
Why?
| | Stroke | 2 | 2022 | 1071 | 0.830 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2022 | 218 | 0.830 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 92 | 0.730 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2021 | 48 | 0.700 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2021 | 25 | 0.700 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 79 | 0.650 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 14 | 0.650 |
Why?
| | Treatment Outcome | 12 | 2023 | 10232 | 0.610 |
Why?
| | Specialization | 1 | 2020 | 143 | 0.610 |
Why?
| | Medicine | 1 | 2020 | 117 | 0.600 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2021 | 270 | 0.600 |
Why?
| | Neuroimaging | 1 | 2020 | 279 | 0.570 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 16 | 0.570 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 41 | 0.560 |
Why?
| | Leptin | 2 | 2008 | 222 | 0.530 |
Why?
| | Retrospective Studies | 12 | 2023 | 14532 | 0.520 |
Why?
| | Healthcare Disparities | 1 | 2022 | 579 | 0.510 |
Why?
| | Lower Extremity | 1 | 2020 | 404 | 0.500 |
Why?
| | Ascites | 1 | 2016 | 44 | 0.500 |
Why?
| | Liver Neoplasms | 1 | 2021 | 635 | 0.490 |
Why?
| | Endovascular Procedures | 1 | 2020 | 301 | 0.490 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1918 | 0.490 |
Why?
| | Hypertension, Portal | 1 | 2016 | 61 | 0.480 |
Why?
| | Logistic Models | 5 | 2021 | 1983 | 0.470 |
Why?
| | Liver Transplantation | 1 | 2023 | 833 | 0.470 |
Why?
| | Humans | 33 | 2024 | 129527 | 0.470 |
Why?
| | Databases, Factual | 6 | 2022 | 1261 | 0.400 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1510 | 0.390 |
Why?
| | Radiography | 3 | 2023 | 798 | 0.380 |
Why?
| | Catheterization | 2 | 2023 | 176 | 0.360 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 234 | 0.350 |
Why?
| | Device Removal | 2 | 2023 | 136 | 0.350 |
Why?
| | Patient Discharge | 3 | 2022 | 854 | 0.350 |
Why?
| | Aged, 80 and over | 7 | 2021 | 7052 | 0.330 |
Why?
| | Aged | 11 | 2022 | 22063 | 0.320 |
Why?
| | Apoptosis | 2 | 2008 | 2488 | 0.310 |
Why?
| | Neoplasms | 1 | 2023 | 2450 | 0.300 |
Why?
| | Muscle Cells | 1 | 2007 | 43 | 0.280 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5078 | 0.280 |
Why?
| | Middle Aged | 10 | 2023 | 31087 | 0.260 |
Why?
| | Cardiomegaly | 1 | 2007 | 170 | 0.260 |
Why?
| | Male | 14 | 2023 | 63586 | 0.260 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 353 | 0.250 |
Why?
| | Hospitals | 2 | 2021 | 649 | 0.230 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 492 | 0.220 |
Why?
| | Cohort Studies | 4 | 2023 | 5423 | 0.220 |
Why?
| | Aldosterone | 1 | 2023 | 43 | 0.210 |
Why?
| | Adrenal Glands | 1 | 2023 | 70 | 0.210 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2734 | 0.210 |
Why?
| | Female | 12 | 2023 | 68650 | 0.200 |
Why?
| | Watchful Waiting | 1 | 2023 | 67 | 0.200 |
Why?
| | Gallbladder Diseases | 1 | 2022 | 10 | 0.200 |
Why?
| | Hospitalization | 3 | 2021 | 2076 | 0.190 |
Why?
| | Adult | 8 | 2021 | 35505 | 0.190 |
Why?
| | Atherectomy | 1 | 2022 | 37 | 0.190 |
Why?
| | Forecasting | 1 | 2024 | 360 | 0.190 |
Why?
| | Cholecystostomy | 1 | 2021 | 4 | 0.180 |
Why?
| | Cholecystitis, Acute | 1 | 2021 | 23 | 0.180 |
Why?
| | Femoral Artery | 1 | 2022 | 174 | 0.180 |
Why?
| | Cholecystectomy | 1 | 2021 | 58 | 0.180 |
Why?
| | Vena Cava, Inferior | 1 | 2021 | 68 | 0.170 |
Why?
| | Oropharynx | 1 | 2020 | 45 | 0.170 |
Why?
| | Mouth | 1 | 2020 | 84 | 0.170 |
Why?
| | Larynx | 1 | 2020 | 59 | 0.170 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.170 |
Why?
| | Radiologists | 1 | 2020 | 41 | 0.160 |
Why?
| | Cardiologists | 1 | 2020 | 46 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 201 | 0.160 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 57 | 0.160 |
Why?
| | Time Factors | 3 | 2020 | 6530 | 0.160 |
Why?
| | Hemorrhage | 1 | 2023 | 680 | 0.150 |
Why?
| | Odds Ratio | 1 | 2021 | 1018 | 0.150 |
Why?
| | Recurrence | 1 | 2021 | 1011 | 0.150 |
Why?
| | Acute Disease | 1 | 2021 | 975 | 0.150 |
Why?
| | Inpatients | 2 | 2019 | 476 | 0.150 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 566 | 0.140 |
Why?
| | Socioeconomic Factors | 1 | 2022 | 1211 | 0.140 |
Why?
| | Vascular Patency | 1 | 2018 | 102 | 0.140 |
Why?
| | Venous Thromboembolism | 2 | 2018 | 287 | 0.140 |
Why?
| | Adolescent | 6 | 2021 | 20409 | 0.140 |
Why?
| | Liver Cirrhosis | 1 | 2019 | 281 | 0.140 |
Why?
| | Radiology Department, Hospital | 1 | 2017 | 15 | 0.140 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 61 | 0.130 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 147 | 0.130 |
Why?
| | Linear Models | 2 | 2017 | 818 | 0.130 |
Why?
| | Cardiovascular Diseases | 1 | 2008 | 1997 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 170 | 0.130 |
Why?
| | Inservice Training | 1 | 2017 | 108 | 0.130 |
Why?
| | Personnel Selection | 1 | 2017 | 70 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2020 | 507 | 0.120 |
Why?
| | Surgeons | 1 | 2020 | 264 | 0.120 |
Why?
| | Obesity | 1 | 2008 | 2875 | 0.120 |
Why?
| | Hospital Mortality | 2 | 2018 | 851 | 0.120 |
Why?
| | Comorbidity | 2 | 2018 | 1548 | 0.120 |
Why?
| | Prevalence | 1 | 2021 | 2561 | 0.110 |
Why?
| | Faculty, Medical | 1 | 2017 | 268 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1050 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2724 | 0.100 |
Why?
| | Anticoagulants | 1 | 2017 | 637 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1049 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1491 | 0.100 |
Why?
| | Young Adult | 4 | 2021 | 12438 | 0.100 |
Why?
| | Sex Factors | 1 | 2018 | 1966 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4891 | 0.090 |
Why?
| | Risk Factors | 3 | 2017 | 9779 | 0.090 |
Why?
| | Heart Failure | 2 | 2018 | 2143 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2022 | 128 | 0.090 |
Why?
| | Length of Stay | 1 | 2016 | 1132 | 0.090 |
Why?
| | Positron-Emission Tomography | 2 | 2022 | 282 | 0.080 |
Why?
| | Survival Rate | 2 | 2018 | 1870 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2342 | 0.080 |
Why?
| | Rats, Zucker | 1 | 2008 | 30 | 0.080 |
Why?
| | Mice, Obese | 1 | 2007 | 63 | 0.070 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2007 | 80 | 0.070 |
Why?
| | Caspase 3 | 1 | 2007 | 244 | 0.070 |
Why?
| | Catalysis | 1 | 2007 | 311 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 956 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1842 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2393 | 0.050 |
Why?
| | Myocardium | 1 | 2007 | 981 | 0.050 |
Why?
| | Interdisciplinary Research | 1 | 2022 | 26 | 0.050 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 87 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 167 | 0.050 |
Why?
| | Gallbladder | 1 | 2021 | 17 | 0.050 |
Why?
| | Laryngeal Neoplasms | 1 | 2020 | 31 | 0.040 |
Why?
| | Insulin Resistance | 1 | 2008 | 1168 | 0.040 |
Why?
| | Rats | 1 | 2008 | 5470 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 622 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 647 | 0.040 |
Why?
| | Hospital Bed Capacity | 1 | 2018 | 25 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4073 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2018 | 113 | 0.040 |
Why?
| | Hospitals, Urban | 1 | 2018 | 135 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 195 | 0.030 |
Why?
| | Animals | 2 | 2008 | 35334 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 304 | 0.030 |
Why?
| | Signal Transduction | 1 | 2008 | 4916 | 0.030 |
Why?
| | Career Choice | 1 | 2017 | 206 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1201 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 514 | 0.030 |
Why?
| | Age Factors | 1 | 2018 | 3150 | 0.020 |
Why?
| | Mice | 1 | 2007 | 16973 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2694 | 0.020 |
Why?
| | Curriculum | 1 | 2017 | 922 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7150 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5429 | 0.020 |
Why?
| | Child, Preschool | 1 | 2017 | 10499 | 0.010 |
Why?
| | Child | 1 | 2017 | 20932 | 0.010 |
Why?
|
|
Trivedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|